Where is Kaleido Biosciences’ corporate headquarters?
65 Hayden Avenue
Lexington, MA 02421
Where is the company incorporated?
Kaleido Biosciences is incorporated under the laws of the State of Delaware.
When was Kaleido founded?
Kaleido was founded in 2015.
When did Kaleido go public?
Kaleido’s initial public offering (IPO) occurred on February 28, 2019.
What is Kaleido’s fiscal year?
The Company’s fiscal year begins on January 1st and ends on December 31st.
How is Kaleido’s stock traded, under which ticker, and what is its CUSIP number?
Kaleido is traded under the ticker symbol KLDO on the NASDAQ Global [Select] Market. The CUSIP number is 483347 100.
Does Kaleido issue dividends on its common stock?
Kaleido does not pay cash dividends on its common stock and does not anticipate doing so in the foreseeable future.
Who is Kaleido's transfer agent?
Computershare Trust Company, N.A.
Whom do I contact with questions about my stock?
Please contact Computershare Customer Service. Computershare representatives can provide you with information about your account, instructions for how to change your address and can also provide detailed instructions about how to transfer ownership.
(800) 736-3001 (US, Canada, Puerto Rico)
(781) 575-3100 (non-US)
P.O. Box 505000
Louisville, KY 40233-5000
By overnight delivery:
462 South 4th Street, Suite 1600
Louisville, KY 40202
Does Kaleido have a direct stock purchase plan?
Kaleido does not offer direct purchase of its stock. Common stock of Kaleido can be bought or sold through a stockbroker or financial institution that offers brokerage services.
Who is Kaleido's auditor?
Deloitte & Touche LLP
200 Berkley Street, 10th floor
Boston, MA 02116(617) 437 2000
Who is Kaleido's outside legal counsel?
Goodwin Procter LLP
100 Northern Avenue
Boston, MA 02210(617) 570-1000
How can I receive the latest corporate news releases and financial reports?
How can I view documents Kaleido has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Whom should I contact regarding investor inquiries?